Anti-ETAR autoantibodies are more prevalent in SLE-PAH patients than those without PAH, and they trigger inflammation, cell proliferation, and vasoconstriction, positively correlating with systolic PAP. The gene discussed is EDNRA; the disease is systemic lupus erythematosus.